Prosecution Insights
Last updated: October 25, 2026

Indiana University Research and Technology Corporation

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering

4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Analysis

Indiana University Research and Technology Corporation has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 4 actions are assigned to 4 distinct examiners across 3 distinct art units. MINCHELLA, ADAM ZACHARY is the busiest examiner with 1 pending office action, showing a diverse but distributed prosecution profile. This distribution suggests a lack of examiner concentration, which may lead to varied prosecution experiences across the portfolio.

The 3 distinct art units involved indicate that while the portfolio is centered on Biotechnology & Pharmaceuticals, it touches upon different technical niches. For a practitioner, this means that there is no single examiner whose historical data will dominate the outcome of the current docket. The presence of 4 distinct examiners requires a flexible prosecution strategy that can adapt to the different standards and practices of these various individuals.

With 4 pending office actions and 3 distinct art units, the company's innovations are being reviewed by multiple specialized groups within the USPTO. This breadth suggests that the biotechnology focus covers several sub-specialties. The 4 distinct examiners ensure that the 4 pending office actions are each given an independent look, reducing the risk that a single examiner's bias could affect a large portion of the company's active applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (75%)
0
Medium (0%)
1
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (25%)
§101 + other1 (25%)
§112 only1 (25%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
50% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MINCHELLA, ADAM ZACHARY 1 63.8% +34.1%
BALAJ, ANTHONY MICHAEL 1 31.2% +29.2%
WRIGHT, ERIC BRANDON 1 0.0% +0.0%
STAVROU, CONSTANTINA E 1 42.4% +35.6%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17119484 DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS STAVROU, CONSTANTINA E 44d overdue
18605786 GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE TREM2 P.R47H AND METHODS OF USE THEREOF WRIGHT, ERIC BRANDON 27d
18966692 SYSTEM AND METHOD FOR DIAGNOSING SLEEP DISORDERS MINCHELLA, ADAM ZACHARY —
18743003 SYSTEMS AND METHODS FOR ACCESSING, COMBINING AND COLLABORATIVE FILTERING OF INFORMATION FROM MULTIPLE ELECTRONIC HEALTH RECORDS BALAJ, ANTHONY MICHAEL —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17119484 DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS STAVROU, CONSTANTINA E 44d overdue
18966692 SYSTEM AND METHOD FOR DIAGNOSING SLEEP DISORDERS MINCHELLA, ADAM ZACHARY —
18743003 SYSTEMS AND METHODS FOR ACCESSING, COMBINING AND COLLABORATIVE FILTERING OF INFORMATION FROM MULTIPLE ELECTRONIC HEALTH RECORDS BALAJ, ANTHONY MICHAEL —

Top Art Units

Art UnitApps
1632 2
3794 1
3682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18966692 SYSTEM AND METHOD FOR DIAGNOSING SLEEP DISORDERS MINCHELLA, ADAM ZACHARY 3794 §103§112 Non-Final OA — Pending Dec 03, 2024
18743003 SYSTEMS AND METHODS FOR ACCESSING, COMBINING AND COLLABORATIVE FILTERING OF INFORMATION FROM MULTIPLE ELECTRONIC HEALTH RECORDS BALAJ, ANTHONY MICHAEL 3682 §101 Non-Final OA — Pending Jun 13, 2024
18605786 GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE TREM2 P.R47H AND METHODS OF USE THEREOF WRIGHT, ERIC BRANDON 1632 §112 Final Rejection 27d Pending Mar 14, 2024
17119484 DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS STAVROU, CONSTANTINA E 1632 §101§102§103 Non-Final OA 44d overdue Pending Dec 11, 2020

Managing Indiana University Research and Technology Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Indiana University Research and Technology Corporation have?

Indiana University Research and Technology Corporation has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.

Which USPTO examiner handles the most Indiana University Research and Technology Corporation applications?

Adam Zachary Minchella has the most, with 1 of Indiana University Research and Technology Corporation's pending office actions.

What technology area are Indiana University Research and Technology Corporation's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month